The Usefulness of Enhanced Recovery after Surgery (ERAS<SUP>®</SUP>) for Pancreaticoduodenectomy
Koichi Teramura(National Cancer Center Hospital East), Satoshi Hirano(Hokkaido University of Science), Shintaro Takeuchi(Teine Keijinkai Hospital), Yusuke Watanabe(Hokkaido University), Eiji Tamoto(Teine Keijinkai Hospital), Satoshi Ishihara(Teine Keijinkai Hospital), Kiyotaka Imamura(Teine Keijinkai Hospital), Fumitaka Nakamura, Nobuichi Kashimura, Minoru Takada(Kindai University Hospital), Yoshiyasu Ambo(Hokkaido University of Science)
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
January 1, 2018
Cited by 1
Related Papers
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer
|Annals of Surgery|2007|315
Clinical practice guidelines for the management of biliary tract cancers 2015: the 2<sup>nd</sup> English edition
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|300